|
KLRAQ1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.534400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.945800E-01 |
| Normal-vs-Stage2 |
5.756300E-02 |
| Normal-vs-Stage3 |
1.120020E-02 |
| Normal-vs-Stage4 |
6.715800E-02 |
| Stage1-vs-Stage2 |
1.080760E-01 |
| Stage1-vs-Stage3 |
9.597000E-03 |
| Stage1-vs-Stage4 |
1.148580E-01 |
| Stage2-vs-Stage3 |
9.321400E-01 |
| Stage2-vs-Stage4 |
7.894400E-01 |
| Stage3-vs-Stage4 |
6.630600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.207800E-02 |
| Normal-vs-AfricanAmerican |
4.903200E-01 |
| Normal-vs-Asian |
1.734350E-01 |
| Caucasian-vs-AfricanAmerican |
6.115400E-01 |
| Caucasian-vs-Asian |
6.335300E-03 |
| AfricanAmerican-vs-Asian |
1.292040E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.868100E-02 |
| Normal-vs-Female |
2.255800E-01 |
| Male-vs-Female |
4.126600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.555600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.517200E-01 |
| Normal-vs-Age(61-80Yrs) |
8.211000E-04 |
| Normal-vs-Age(81-100Yrs) |
2.098400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.818400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.922440E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.837800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.936300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.172210E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.012400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.079980E-03 |
| Classical-VS-Follicular |
1.514240E-01 |
| Classical-VS-Other |
6.173600E-01 |
| Classical-VS-Normal |
4.293800E-01 |
| Tall-VS-Follicular |
2.003800E-01 |
| Tall-VS-Other |
5.696200E-01 |
| Tall-VS-Normal |
1.861360E-03 |
| Follicular-VS-Other |
9.958400E-01 |
| Follicular-VS-Normal |
8.654300E-02 |
| Other-VS-Normal |
3.774400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.729800E-01 |
| Normal-vs-N1 |
7.164100E-02 |
| N0-vs-N1 |
2.989200E-01 |
|
|
